The DM Trio™ are three (3) individual FDA Cleared tools that assess the autonomic nervous system (ANS), diabetic peripheral neuropathy (DPN), and peripheral arterial disease (PAD). 

The DM Trio™ are three (3) individual medical devices with three (3) individual reports (as CMS requires) with the following features: 

• Measurement of Peripheral Artery Disease (PAD)

• Measurement of the Sympathetic Skin Response (SSR) for the sudomotor function testing (small fiber) 

• Measurement of the Sympathetic Skin Response (SSR) for the loss of protective sensation (large fiber)

• Measuring the Autonomic Nervous System (ANS) via Heart Rate Variability or Hypertension

Diabetic Neuropathy Device™ www.DPNtest.org is the First FDA Cleared Multi-Objective Innovation that Identifies, and Measures Peripheral Neuropathy. 

Autonomic Nervous System (ANS) www.ANStest.org device is FDA Cleared and Measures Arterial Stiffness, Vascularization, and Endothelial Function.

TruPAD™ www.TruPAD.org is a medical device that measures Peripheral Artery Disease (PAD), a condition in which the large and medium-sized arteries supply blood to the legs and become narrow or clogged with plaque, constricting blood flow. 

Features of the tests:

• Non-Invasive

• <3-minutes each to complete

• FDA Cleared with recommended billing codes

• Easy to interpret color-coded reports

• Allows provider to perform and bill for up to 4 billing codes